CENTOGENE NV (CNTG) Stock Price & Overview
NASDAQ:CNTG • NL0014040206
Current stock price
The current stock price of CNTG is 0.325 USD. Today CNTG is down by -6.23%. In the past month the price decreased by -33.52%. In the past year, price decreased by -68.45%.
CNTG Key Statistics
- Market Cap
- 8.97M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.39
- Dividend Yield
- N/A
CNTG Stock Performance
CNTG Stock Chart
CNTG Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CNTG. When comparing the yearly performance of all stocks, CNTG is a bad performer in the overall market: 92.29% of all stocks are doing better.
CNTG Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CNTG. Both the profitability and financial health of CNTG have multiple concerns.
CNTG Earnings
CNTG Forecast & Estimates
7 analysts have analysed CNTG and the average price target is 1.53 USD. This implies a price increase of 370.77% is expected in the next year compared to the current price of 0.325.
For the next year, analysts expect an EPS growth of 39.38% and a revenue growth 22.37% for CNTG
CNTG Groups
Sector & Classification
CNTG Financial Highlights
Over the last trailing twelve months CNTG reported a non-GAAP Earnings per Share(EPS) of -1.39. The EPS decreased by -6.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.05% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
CNTG Ownership
CNTG Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.84 | 100.301B | ||
| CI | THE CIGNA GROUP | 8.75 | 73.416B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.51 | 29.676B | ||
| LH | LABCORP HOLDINGS INC | 14.54 | 22.517B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.93 | 21.735B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.434B | ||
| DVA | DAVITA INC | 10.6 | 10.065B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 32.61 | 8.834B | ||
| AGL | AGILON HEALTH INC | N/A | 8.231B | ||
| CHE | CHEMED CORP | 15.97 | 5.382B | ||
| OPCH | OPTION CARE HEALTH INC | 15.34 | 4.611B | ||
| HIMS | HIMS & HERS HEALTH INC | 35.85 | 4.502B | ||
| RDNT | RADNET INC | 69.26 | 4.352B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CNTG
Company Profile
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company is headquartered in Rostock, Mecklenburg-Vorpommern and currently employs 493 full-time employees. The company went IPO on 2019-11-07. The firm focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The firm's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The firm's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The firm's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.
Company Info
IPO: 2019-11-07
CENTOGENE NV
Am Strande 7
Rostock MECKLENBURG-VORPOMMERN 18055 DE
CEO: Andrin Oswald
Employees: 493
Phone: 4938180113400
CENTOGENE NV / CNTG FAQ
Can you describe the business of CENTOGENE NV?
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company is headquartered in Rostock, Mecklenburg-Vorpommern and currently employs 493 full-time employees. The company went IPO on 2019-11-07. The firm focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The firm's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The firm's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The firm's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.
What is the stock price of CENTOGENE NV today?
The current stock price of CNTG is 0.325 USD. The price decreased by -6.23% in the last trading session.
Does CENTOGENE NV pay dividends?
CNTG does not pay a dividend.
What is the ChartMill rating of CENTOGENE NV stock?
CNTG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is CENTOGENE NV worth?
CENTOGENE NV (CNTG) has a market capitalization of 8.97M USD. This makes CNTG a Nano Cap stock.
What is the next earnings date for CNTG stock?
CENTOGENE NV (CNTG) will report earnings on 2024-09-04.
Who owns CENTOGENE NV?
You can find the ownership structure of CENTOGENE NV (CNTG) on the Ownership tab.